Suppr超能文献

人肿瘤中米索硝唑水平明显较低的原因。

Causes of apparent low levels of misonidazole in human tumours.

作者信息

Ash D V, Smith M R

出版信息

Clin Radiol. 1980 Mar;31(2):233-7. doi: 10.1016/s0009-9260(80)80172-3.

Abstract

Although the concentration of misonidazole measured in human tumours may appear to be only 50--70% of the corresponding blood level, the concentration within the intra- and extracellular fluid of the tumour may be nearer 100% of the blood level. Causes for these apparent low levels of drug which have been investigated are: 1. Presence of fat in the tissue. 2. Presence of non-cellular material in the tissue. 3. Degradation of the drug by anaerobic metabolism after biopsy. An in vitro experiment to test the partitior fractionation study of the distribution of misonidazole showed that it is distributed mainly in the fluid compartment of the cell and that overall drug levels in tissue are related to the fluid content of the tissue. Serial measurements of misonidazole on tissue after removal from the body have shown that breakdown of the drug occurs when the tissue becomes anoxic. These results suggest that the concentration of misonidazole present within tumour cells is higher than the overall level measured for the tissue and that the enhancement ratio to be expected may therefore be higher also.

摘要

尽管在人类肿瘤中测得的米索硝唑浓度似乎仅为相应血液水平的50%-70%,但肿瘤细胞内和细胞外液中的浓度可能更接近血液水平的100%。已对这些明显的低药物水平原因进行了研究,包括:1. 组织中存在脂肪。2. 组织中存在非细胞物质。3. 活检后药物通过无氧代谢降解。一项测试米索硝唑分布的分配分数研究的体外实验表明,它主要分布在细胞的液相中,并且组织中的总体药物水平与组织的液体含量相关。从体内取出后对组织进行的米索硝唑系列测量表明,当组织缺氧时药物会分解。这些结果表明,肿瘤细胞内的米索硝唑浓度高于组织测量的总体水平,因此预期的增强比可能也更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验